SoftOx Solutions is trading 6.3% up at NOK 0.11, after rising from NOK 0.10 on September 4, 2026; no clear catalyst has been identified.
- No major company-specific announcement dated September 16 was identified.
- Recent developments include positive SIS-03 safety data and the first patient dosed in the proof-of-concept trial, but both announcements predate the move.
- The biotechnology sector was weaker, so the gain does not align with the provided sector trend.